Clinical features predicting mortality (M) in high risk febrile neutropenic cancer children (HRNTPCH) at Hospital de Niños Ricardo Gutiérrez (HNRG), Argentina  by Rivas, N. et al.
e th In
8
T
m
i
J
A
1
U
2
3
t
f
w
i
ﬁ
v
e
f
t
r
s
t
t
b
U
t
2
I
d
o
w
w
o
s
s
m
u
s
w
n
d
8
C
f
p
N
H
A
T
t
i
i
H
E
E
p
f
(
l
d
c
2
y
m
(
2
3
r
(
i
p
v
7
1
p
2
g
P
3
i
G
p
d
8
N
c
C
P
A
1
C
2
3
4
c
f
c
b
s
l416 14
0.007
he feasibility of rectal artesunate as pre-referral treat-
ent for severe malaria in under ﬁves at community level
n rural Uganda
. Rujumba1, E.A. Mworozi 1,∗, B.A. Mpeka2, T. Lutalo2, R.
zairwe3
Makerere University College of Health Sciences, Kampala,
ganda
Ministry of Health, kampala, Uganda
WHO- Uganda Country Ofﬁce, kampala, Uganda
Background: Malaria is the leading cause of child mor-
ality especially in under ﬁve children. It is responsible
or 1-2million deaths and 300-500million clinical cases
orldwide annually (WHO 2003); 90% of the cases are
n sub-Saharan Africa and majority are children under
ve. Most deaths result from delayed treatment due to
arious causes. Treatment of severe malaria requires par-
nteral drugs and skilled personnel yet peripheral health
acilities are poorly equipped for this. Timely efﬁcacious
reatment at community can ‘‘buy’’ time for patients to
each health facilities. Artemisinin derivatives have been
hown to cause rapid reduction of parasite load and resolu-
ion of clinical malaria symptoms. We conducted a study
o design and evaluate systems for effective community
ased treatment of severe malaria in underﬁves in 2 rural
gandan districts using rectal Artesunate as pre-referral
reatment.
Methods: Randomized community trial carried out from
004-2007. Study phases were formative, development of
EC materials, selection and training of drug distributors,
eployment and monitoring of study drug.
Results: Acceptability of Rectal Artesunate in treatment
f severe malaria in under-ﬁve children at community level
as high. A total of 1502 children with severe malaria
ere recruited and referred. A total of 1469/1502 (98%)
f treated children recovered, 33(2%) died mainly due to
evere anaemia.
Conclusion: Majority (98%) of the treated children with
evere malaria recovered. Use of rectal Artesunate at com-
unity level reduced mortality due to severe malaria in
nder-ﬁves and community delivery systems for Rectal Arte-
unate are feasible and should be scaled-up in rural areas
here accessibility to parental and anti malarial therapy is
ot feasible.
oi:10.1016/j.ijid.2010.02.545
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linical features predicting mortality (M) in high risk
ebrile neutropenic cancer children (HRNTPCH) at Hos-
ital de Nin˜os Ricardo Gutiérrez (HNRG), Argentina
. Rivas ∗, A. Vin˜a, G. Yerino, C. Ceccoli, F. Plat, C.
ascalovici, E.L. Lopez
Hospital de Nin˜os ‘‘Ricardo Gutiérrez’’, Buenos Aires,
rgentina
Background: Mortality is the major concern in HR NTPCH.
o detect associated factors on admission and during hospi-
alization is important to decrease it The objective was to
r
c
t
pternational Congress on Infectious Diseases (ICID) Abstracts
dentify clinical (c) and microbiological (m) factors predict-
ng M in HRNTPCH
Methods: Prospective cohort study from 1/02 to 12/07 at
NRG. HR-NTPCH were deﬁned according to IDSA criteria.
xclusion: All NTPCH that did not fullﬁed the HR criteria.
ndpoint: Mortality. Predictive factors assessed for M: hos-
italization in last 10 days (PH), underlying disease (UD),
ever (F) and clinical focus in admission (CF), bacteremia
B), sepsis(S), positive culture (PC) and polimicrobial iso-
ations (PI), intensity(IN) and duration of neutropenia (DN),
uration of fever (DF), days of hospitalization (HD) and noso-
omial infection. Demographic data were also analized. Chi
and Mann-Whithney test were used in the univariate anal-
sis. All factors with p < 0.05 were included in a regression
odel.
Results: Population 501 episodes/267 pts. M 13/501
2,6%), survivals 488/501 (97,4%). Age(med) 87 (5-
19)mo, male 231/501(46.5%) and UD: hematologic tumors
50/501(70%). No signiﬁcant difference between groups in
elation to age, gender or UD was observed. 58/501pts
12%) had not a focus, 216/501(43%) had m demostrated
nfection and 227/501(45%) had only c ﬁndings. S was
resent in 85 pts, 12 of them in M group: 12/13 (92,3%)
s C 73/488(14,9%) p < 0,001. Nosocomial pneumonia(NP)
/13(54%) vs 51/488(10.5) p < 0.001; PI 5/13 (38.5%) vs
5/488 (3%) p < 0.001, B 7/13 (54%) vs 85/488 (17.4%),
0,0008; PC 10/13 (77%) vs 204/488 (42%) p 0,011; and HD
2 (1- 100) vs 8(2-110)d, p0,026 also differed between M
roup and C. No statistical difference was found in F, CF,
H, IN,DN and DF. In multivariate analysis: S, p0.002-OR
3.6,NP, p0.009 OR 7.2 and PI, p0.048 OR 7.5 remained as
ndependent risk factors for M. In M, PI were Gram - 7/10,
ram+ 2/10 and fungi 1/10.
Conclusion: The presence of S, NP and PI should alert
hysicians to extreme health care attention in HR-NTPCH.
oi:10.1016/j.ijid.2010.02.546
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on-typeable Haemophilus inﬂuenzae and Streptococ-
us pneumoniae: Primary causes of acute otitis media in
olombian children
. Lopez1, A. Sierra1,∗, M.A. Zapata1, B. Vanegas1, R. De
ntonio2, M.M. Castrejon2, W. Hausdorff3, R. Colindres4
Centro de Estudios en Infectologia Pediatrica CEIP, Cali,
olombia
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GlaxoSmithKline Biologicals, Wavre, Belgium
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Background: Acute otitis media (AOM) is one of the most
ommon bacterial infections in childhood and the most
requent reason for antibiotic use. Bacterial conjugate vac-
ines have demonstrated some efﬁcacy in preventing AOM,
ut impact may vary according to underlying pathogen and
erotype distribution. Because data from Latin America are
imited, this report provides novel data regarding bacte-
ial etiology and serotypes of AOM cases within a routine
linical setting in two medical centers in Cali, Colombia
o determine what proportion of disease may be vaccine-
reventable.
